Real-World Efficacy and Safety of Eribulin in Advanced and Pretreated HER2-negative Breast Cancer in a Spanish Comprehensive Cancer Center

BMC pharmacology & toxicology - United Kingdom
doi 10.1186/s40360-019-0367-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Eribulin in Pretreated Metastatic Breast Cancer Patients: Results of the TROTTER Trial—a Multicenter Retrospective Study of Eribulin in Real Life

SpringerPlus
Multidisciplinary
2016English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

Real-World Patient- And Caregiver-Reported Outcomes in Advanced Breast Cancer

Current Oncology
Oncology
2018English

Olaparib in the Therapy of Advanced Ovarian Cancer: First Real World Experiences in Safety and Efficacy From China

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Scientific Reports
Multidisciplinary
2019English

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer With HER2-Overexpression: A Network Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Eribulin for the Treatment of Metastatic Breast Cancer: An Update on Its Safety and Efficacy

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2015English

Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer

Journal of Cancer
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy